Abstract
Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.
Original language | English (US) |
---|---|
Pages (from-to) | 95-96 |
Number of pages | 2 |
Journal | Pharmacopsychiatria |
Volume | 15 |
Issue number | 3 |
DOIs | |
State | Published - May 1982 |
Externally published | Yes |
ASJC Scopus subject areas
- Medicine(all)